Live from the NIH registry
Studies recruiting near Rancho Cucamonga right now
Top 25 of 1,457 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (23.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
UCIMedical Center — Orange, California (28.5 mi)
· Sponsor: University of California, Irvine
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL)
Phase 1
Interventional 106 participants sought
City of Hope — Duarte, California (23.5 mi)
· Sponsor: Umoja Biopharma
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Providence Medical Foundation ( Site 0141) — Fullerton, California (27.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
City of Hope — Duarte, California (23.5 mi)
· Sponsor: Nurix Therapeutics, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (28.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: PeproMene Bio, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Dream Team Clinical Research — Pomona, California (11.7 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Southern CA — Redlands, California (22.5 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Phase 2
Interventional 23 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (28.5 mi)
· Sponsor: University of California, Irvine
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Providence Medical Foundation — Fullerton, California (27.0 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Kaiser Permanente-Ontario — Ontario, California (6.4 mi)
· Sponsor: National Cancer Institute (NCI)
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
City of Hope — Duarte, California (23.5 mi)
· Sponsor: Adela, Inc
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 83 participants sought
Research Site — Duarte, California (23.5 mi)
· Sponsor: AstraZeneca
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Catalina Research Institute, LLC — Montclair, California (7.8 mi)
· Sponsor: Biomea Fusion Inc.
A Long-Term Observational Study of Patients With Fucosidosis
Fucosidosis
N/A
Observational 57 participants sought
Children's Hospital of Orange County — Orange, California (28.5 mi)
· Sponsor: JCR Pharmaceuticals Co., Ltd.
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Children's Hospital of Orange County — Orange, California (28.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Gastrointestinal Cancer, Peritoneal Carcinomatosis
EARLY/Phase 1
Interventional 10 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (28.5 mi)
· Sponsor: University of California, Irvine
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Cesarean Section Complications, Cesarean Section; Infection
N/A
Interventional 400 participants sought
Loma Linda University — Loma Linda, California (18.3 mi)
· Sponsor: Loma Linda University
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2
Interventional 35 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: City of Hope Medical Center
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Solid Tumor, Advanced Cancer
Phase 1
Interventional 330 participants sought
Stern Center for Cancer Clinical Trials and Research — Orange, California (28.5 mi)
· Sponsor: I-Mab Biopharma US Limited
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Innovative Clinical Research Institute — Whittier, California (28.5 mi)
· Sponsor: Zenith Epigenetics
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Dental Pain and Sensation Disorder, Pain, Postoperative
Phase 4
Interventional 98 participants sought
Loma Linda University Health — Loma Linda, California (18.3 mi)
· Sponsor: Loma Linda University
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Thyroid Gland Carcinoma
N/A
Interventional 1,450 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: City of Hope Medical Center
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Unresectable, Locally Advanced
Phase 1, Phase 2
Interventional 170 participants sought
City of Hope — Duarte, California (23.5 mi)
· Sponsor: Recursion Pharmaceuticals Inc.